Close Menu

GSK

Efforts spearheaded by Sage Bionetworks and Genetic Alliance hope to encourage drug developers to share precompetitive genomic data from the comparator arms of drug trials and to give study participants more control over their own data generated in clinical investigations.

The funding is for seven projects aimed at creating biomarkers to help guide patients to the most appropriate treatments and at creating drugs and companion diagnostics.

The company will work with Pfizer's Pain & Sensory Disorders and Regenerative Medicine unit on the project using its Episphere chemoproteomics platform.

However, the company confirmed that it is no longer commercializing its test, the Enigma ML Influenza A/B detection assay, in partnership with GlaxoSmithKline as was previously reported.

The investment will be used to further grow partnerships with pharma and biotech companies as well as to pursue identification of prognostic and diagnostic protein biomarkers for cancer, the company said.

A Finnish government task force plans to release its final report on Aug. 31 after conducting further investigations into the epidemiologic, immunologic, and genetic causes for the onset of narcolepsy following vaccination with Pandemrix.

Achievement of the milestone, which triggered a payment of an undisclosed amount, comes two months after the company reached its first milestone in the collaboration.

The collaboration covers use of Cellzome's Episphere technology in search for potential drug candidates.

The agreement calls for Sanofi-Aventis to make to OBT an undisclosed upfront cash payment, with OBT eligible for future development, regulatory, and performance milestone payments and royalties on worldwide product sales.

Movers & Shakers: Jan 21, 2011

Premium

Tachi Yamada, Roger Hayes

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.